Martine van Vugt
Director/Board Member at SCANDION ONCOLOGY A/S
Martine van Vugt active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 29/03/2023 | - |
| Human Resources Officer | 01/01/2019 | 29/03/2023 | |
| SCANDION ONCOLOGY A/S | Director/Board Member | 01/04/2022 | - |
| Independent Dir/Board Member | 01/04/2022 | - | |
Immagene BV
 Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Director/Board Member | - | - |
| Hollandbio | Director/Board Member | - | - |
Career history of Martine van Vugt
Former positions of Martine van Vugt
| Companies | Position | Start | End |
|---|---|---|---|
| TME PHARMA N.V. | Director/Board Member | 24/06/2021 | 29/06/2023 |
| Independent Dir/Board Member | 24/06/2021 | 29/06/2023 |
Training of Martine van Vugt
| Wageningen University | Graduate Degree |
| University of Utrecht | Doctorate Degree |
Statistics
International
| Netherlands | 5 |
| Denmark | 3 |
| Germany | 2 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Human Resources Officer | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| TME PHARMA N.V. | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Private companies | 2 |
|---|---|
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |
| Hollandbio |
- Stock Market
- Insiders
- Martine van Vugt
- Experience